StockViz
Share URL
Embed chart view
-
Export .csv
-
Download image
-
Copy link
-
Embed code
StockViz
RANKINGS
SCHOTT Pharma AG & Co. KGaA
Frankfurt Stock Exchange:1SXP.F
Sector
Location
Market Cap
USD 4.58 B
Share Price
USD 29.59
Avg Daily Volume
165
Change (1 day)
-1.10%
Change (1 year)
-17.82%
Change (YTD)
13.00%
SCHOTT Pharma AG & Co. KGaA EBITDA Margin for the year ending September 30, 2024: 27.42%
SCHOTT Pharma AG & Co. KGaA EBITDA Margin is 27.42% for the year ending September 30, 2024, a 8.24% change year over year. EBITDA Ratio is the proportion of Earnings Before Interest, Taxes, Depreciation, and Amortization to total revenue, assessing a company's operational profitability before non-operating expenses and non-cash charges.
-
SCHOTT Pharma AG & Co. KGaA EBITDA Margin for the year ending September 30, 2023 was 25.33%, a 2.43% change year over year.
-
SCHOTT Pharma AG & Co. KGaA EBITDA Margin for the year ending September 30, 2022 was 24.73%, a 8.78% change year over year.
-
SCHOTT Pharma AG & Co. KGaA EBITDA Margin for the year ending September 30, 2021 was 22.73%, a 6.08% change year over year.
-
SCHOTT Pharma AG & Co. KGaA EBITDA Margin for the year ending September 30, 2020 was 21.43%.
Competitors
Chugai Pharmaceutical Co., Ltd.
USD 47.05
4519.T
+0.49
1.05%
West Pharmaceutical Services, Inc.
USD 210.89
WST
-10.70
-4.83%
Yuhan Corporation
USD 94.38
000100.KS
-2.58
-2.66%
Cohance Lifesciences Limited
USD 12.57
COHANCE.NS
-0.17
-1.34%
Gan & Lee Pharmaceuticals.
USD 8.19
603087.SS
+0.02
0.24%
Zhejiang Huahai Pharmaceutical Co., Ltd.
USD 3.10
600521.SS
-0.05
-1.62%
Tonghua Dongbao Pharmaceutical Co., Ltd.
USD 1.15
600867.SS
+0.01
0.62%
Anhui Anke Biotechnology (Group) Co., Ltd.
USD 1.34
300009.SZ
-0.03
-2.33%
Neuland Laboratories Limited
USD 165.51
NEULANDLAB.NS
-2.94
-1.75%
Anbio Biotechnology Class A Ordinary Shares
USD 46.99
NNNN
+3.24
7.41%
Qingdao Baheal Medical Inc.
USD 2.98
301015.SZ
-0.04
-1.37%
Eli Lilly and Company
USD 771.71
LLY
+10.21
1.34%
AbbVie Inc.
USD 189.26
ABBV
-2.14
-1.12%
Roche Holding AG
USD 340.88
RO.SW
+2.44
0.72%
AstraZeneca PLC
USD 138.02
AZN.L
-0.31
-0.22%
Merck & Co., Inc.
USD 79.96
MRK
-1.56
-1.91%
Amgen Inc.
USD 294.76
AMGN
-3.49
-1.17%
Pfizer Inc.
USD 24.47
PFE
-0.11
-0.45%
Gilead Sciences, Inc.
USD 108.22
GILD
-0.58
-0.53%
Sanofi
USD 96.63
SAN.PA
-0.24
-0.24%
Key Data
| Date | EBITDA Margin | Net Income Margin | EBT Margin | Operating Income Margin |
|---|
Competitors
Chugai Pharmaceutical Co., Ltd.
USD 47.05
4519.T
+0.49
1.05%
West Pharmaceutical Services, Inc.
USD 210.89
WST
-10.70
-4.83%
Yuhan Corporation
USD 94.38
000100.KS
-2.58
-2.66%
Cohance Lifesciences Limited
USD 12.57
COHANCE.NS
-0.17
-1.34%
Gan & Lee Pharmaceuticals.
USD 8.19
603087.SS
+0.02
0.24%
Zhejiang Huahai Pharmaceutical Co., Ltd.
USD 3.10
600521.SS
-0.05
-1.62%
Tonghua Dongbao Pharmaceutical Co., Ltd.
USD 1.15
600867.SS
+0.01
0.62%
Anhui Anke Biotechnology (Group) Co., Ltd.
USD 1.34
300009.SZ
-0.03
-2.33%
Neuland Laboratories Limited
USD 165.51
NEULANDLAB.NS
-2.94
-1.75%
Anbio Biotechnology Class A Ordinary Shares
USD 46.99
NNNN
+3.24
7.41%
Qingdao Baheal Medical Inc.
USD 2.98
301015.SZ
-0.04
-1.37%
Eli Lilly and Company
USD 771.71
LLY
+10.21
1.34%
AbbVie Inc.
USD 189.26
ABBV
-2.14
-1.12%
Roche Holding AG
USD 340.88
RO.SW
+2.44
0.72%
AstraZeneca PLC
USD 138.02
AZN.L
-0.31
-0.22%
Merck & Co., Inc.
USD 79.96
MRK
-1.56
-1.91%
Amgen Inc.
USD 294.76
AMGN
-3.49
-1.17%
Pfizer Inc.
USD 24.47
PFE
-0.11
-0.45%
Gilead Sciences, Inc.
USD 108.22
GILD
-0.58
-0.53%
Sanofi
USD 96.63
SAN.PA
-0.24
-0.24%